Aerosurf: Completed Phase IIa enrollment

Discovery Labs completed enrollment of 32 premature infants of 29-34 weeks gestational age in an open-label Phase IIa trial comparing 60 and 90 minutes of aerosolized Aerosurf plus nasal continuous po...